Skip to content
sellWeak cluster of 510b5-1 plan

Jamie L. Reynoso sold $8,760 of CLOV

CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE. 1,921 shares at an average of $4.56, traded Sep 17, 2026, filed Sep 18, 2026.

Warning score
20
Value
$8,760
1,921 shares
Holdings after
2,803,446
-0% from before
From 52-week low
+167%
low $1.70, close $4.54
From 52-week high
-16%
high $5.41, as of Sep 17, 2026

Score components

  • Role
    CEO
    +25
  • Trade size
    $9k at market
    0
  • Share of holdings sold
    Sold 0.1% of holdings
    0
  • Cluster
    5 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CLOVOct 9, 2026 · close 4.79
Since filing Sep 18, 2026: +7.4%SPY +2.2% · excess +5.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001839066-26-000047, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 17, 2026SOpen-market sale
Class A Common Stock10b5-1
-1,921$4.56$8,7602,803,44625 d ago

Related signals

Other insiders at CLOVER HEALTH INVESTMENTS, CORP. /DE and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
13Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$9,288
2,006 shares
-0%
19Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$39k
8,750 shares
-0%
38Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Andrew Toy
Chief Executive Officer
$1.3M
318,806 shares
-3%
10Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Frank Oldakowski
VP OF FINANCE AND CONTROLLER
$15k
3,170 shares
-1%
50Moderate
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Conrad Wai
CEO, Counterpart Health
$1.4M
300,000 shares
-20%
26Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$44k
9,273 shares
-0%
16Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Karen Soares
Chief Legal Officer
$33k
6,846 shares
-0%
40Moderate
CLOVsell 4
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Frank Oldakowski
VP OF FINANCE AND CONTROLLER
$103k
20,000 shares
-7%
19Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Clay Thornton
Interim CFO
$78k
17,775 shares
-1%
29Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Andrew Toy
Chief Executive Officer
$408k
87,798 shares
-1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jamie L. Reynoso sold $8,760 of CLOV | InsiderTell